EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 168 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $791,997,000 | -65.9% | 18,644 | -61.5% | 0.01% | -73.0% |
| Q2 2020 | $2,320,888,000 | +65853.1% | 48,372 | -36.8% | 0.04% | -31.5% |
| Q1 2020 | $3,519,000 | +20.8% | 76,510 | +57.8% | 0.05% | +134.8% |
| Q4 2019 | $2,914,000 | +327.9% | 48,494 | +302.9% | 0.02% | +283.3% |
| Q3 2019 | $681,000 | -9.3% | 12,035 | -15.6% | 0.01% | +20.0% |
| Q1 2018 | $751,000 | -71.2% | 14,258 | -70.8% | 0.01% | -64.3% |
| Q4 2017 | $2,609,000 | -68.3% | 48,847 | -64.6% | 0.01% | -76.3% |
| Q3 2017 | $8,232,000 | +76.1% | 138,030 | +133.0% | 0.06% | +55.3% |
| Q2 2017 | $4,674,000 | +14.2% | 59,246 | +20.1% | 0.04% | +11.8% |
| Q1 2017 | $4,093,000 | -29.1% | 49,346 | -40.1% | 0.03% | -35.8% |
| Q3 2016 | $5,769,000 | – | 82,415 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 113,737 | $3,227 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 236,883 | $6,720,371 | 0.82% |
| Capital Impact Advisors, LLC | 13,607 | $386,031 | 0.47% |
| TANG CAPITAL MANAGEMENT LLC | 80,000 | $2,269,600 | 0.34% |
| BRANDES INVESTMENT PARTNERS, LP | 545,050 | $15,463,069 | 0.33% |
| Watershed Asset Management, L.L.C. | 9,496 | $269,402 | 0.33% |
| Jackson Creek Investment Advisors LLC | 25,164 | $714 | 0.30% |
| SummerHaven Investment Management, LLC | 18,178 | $515,710 | 0.30% |
| Virtus Fund Advisers, LLC | 1,117 | $31,689 | 0.22% |
| Virtus Investment Advisers, Inc. | 7,308 | $207,328 | 0.14% |